Med cannabis definitely crowded. I think in the growing cultivation space is crowded. Pharmaceutical space however is soim, and medlab is aiming for it. Medlab is focusing on a wolrd first nano delivery product. Which varies across the board for other drugs. not just cannabis. Im not concerned about the other players. As medlab has a vast arsenal of products that vary widely in the health space. Like the infant formula space, very crowded but some like a2m stand out among the crowd with a patented product and something unique that the market wants/is waiting for. Medlab aim is to have an alternative (pharmaceutical grade) to opioid use. Somethingg safer, less addictive, more affective. Medlab as a company is in its infancy stage on the cusp of a world first cannabis product. Which is exciting. Growers... not so much as how many growing companies are there world wide.
Despite the crowded cannabis space i think medlab is in a completely different playing field (pharmaceutical field) compared to recreational field.
Imo
Add to My Watchlist
What is My Watchlist?
